Yousif Abdelrahman, DePari Mary, Vitonis Allison F, Harris Holly R, Shafrir Amy L, Terry Kathryn L, Missmer Stacey A, Sasamoto Naoko
Department of Obstetrics and Gynecology, Hurley Medical Center, College of Human Medicine, Michigan State University, Flint, MI, United States.
Department of Obstetrics, Gynecology, and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, United States.
Front Reprod Health. 2023 Dec 15;5:1297907. doi: 10.3389/frph.2023.1297907. eCollection 2023.
Peritoneal fluid is a medium for endometriosis-associated biomarker discovery from which the local peritoneal environment and pathophysiologic pathways are often inferred. Therefore, we evaluated the associations between peritoneal fluid color and volume at time of endometriosis-related laparoscopic surgery with patient characteristics, endometriosis type and lesion location in adolescents and young adults with endometriosis.
We conducted a cross-sectional analysis among 545 patients undergoing surgery for endometriosis who enrolled in the Women's Health Study: from Adolescence to Adulthood cohort study. Patient characteristics, surgically visualized endometriosis phenotypes, and gross characteristics of peritoneal fluid were collected in compliance with World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project (EPHect) tools. Chi-square or Fisher's exact tests were applied to test for differences across categories.
Most of the patients were adolescents or young adults (86% age <25 years) of white race (89%), with only superficial peritoneal lesions and rASRM stage = I/II observed at surgery (both 95%). We observed variation in peritoneal fluid color across different menstrual cycle phases at time of surgery ( = 0.006). Among those who were cycling at time of surgery, endometriosis patients with red peritoneal fluid were most likely to be in the proliferative phase (49%) compared to the secretory phase (27%), while those with yellow or orange peritoneal fluid were most likely to be in the secretory phase (57% and 86% respectively). Yellow color was significantly less common in those taking combined oral contraceptives but much more common with progesterone only formulation exposure ( = 0.002). Peritoneal fluid volume did not differ by cycle phase but was more likely to be low (≤6 ml) for those exposed to hormones at time of surgery ( = 0.01). Those with acyclic pelvic pain were less likely to have red peritoneal fluid ( = 0.001) but had greater volume ( = 0.02) compared to those without.
Our findings highlight the importance of accounting for menstrual cycle phase and hormonal exposures when designing research using peritoneal fluid samples and inferring from biomarker results intended to advance our understanding of endometriosis and associated symptom pathophysiology.
腹腔液是发现与子宫内膜异位症相关生物标志物的一种介质,人们常常据此推断局部腹腔环境和病理生理途径。因此,我们评估了患有子宫内膜异位症的青少年和青年女性在进行与子宫内膜异位症相关的腹腔镜手术时,腹腔液颜色和体积与患者特征、子宫内膜异位症类型及病变位置之间的关联。
我们对参与“女性健康研究:从青春期到成年期”队列研究的545例接受子宫内膜异位症手术的患者进行了横断面分析。按照世界子宫内膜异位症研究基金会子宫内膜异位症表型与生物样本库协调项目(EPHect)工具的要求,收集患者特征、手术中可视化的子宫内膜异位症表型以及腹腔液的大体特征。采用卡方检验或费舍尔精确检验来检测各分类之间的差异。
大多数患者为青少年或青年女性(86%年龄<25岁),白人种族占89%,手术中仅观察到浅表性腹腔病变且rASRM分期为I/II期(均为95%)。我们观察到手术时不同月经周期阶段的腹腔液颜色存在差异(P = 0.006)。在手术时处于月经周期的患者中,腹腔液为红色的子宫内膜异位症患者处于增殖期的可能性最大(49%),而处于分泌期的可能性为27%,而腹腔液为黄色或橙色的患者处于分泌期的可能性最大(分别为57%和86%)。服用复方口服避孕药的患者中黄色腹腔液明显较少见,但仅使用孕激素制剂的患者中黄色腹腔液则更为常见(P = 0.002)。腹腔液体积在不同月经周期阶段并无差异,但手术时接受激素治疗的患者腹腔液体积更可能较低(≤6 ml)(P = 0.01)。与无周期性盆腔疼痛的患者相比,有周期性盆腔疼痛的患者腹腔液为红色的可能性较小(P = 0.001),但腹腔液体积更大(P = 0.02)。
我们的研究结果强调,在设计使用腹腔液样本的研究并根据生物标志物结果推断以增进我们对子宫内膜异位症及相关症状病理生理学的理解时,考虑月经周期阶段和激素暴露情况的重要性。